We investigated its role in kidney inflammation and fibrosis in a murine model of lupus nephritis (LN), and the clinico-pathological ... Five to ten non-overlapping images were taken for each specimen ...

Case presentation: We present the severe case report of a patient who was diagnosed with lupus nephritis (LN) with gastrointestinal ... low IgG levels and frequent infections. This is a real-world ...

Medical history, serological markers and images were collected ... old female with Fitzpatrick skin-type V and a 17-year history of SLE, based on class II lupus nephritis (LN), CLE, leucopenia, ANA ...

Males with lupus nephritis had higher all-cause mortality and proportion of infection-related death compared to females.

Regular assessment of renal function, proteinuria, and serological markers is crucial for monitoring lupus nephritis progression and treatment response. Long-term follow-up data offer valuable ...

Drug interactions, patient characteristics, and steroid use are critical in LN management, influencing treatment choices and outcomes. Nephrologists focus on renal preservation, while ...

While GSK’s Benlysta (belimumab) and Aurinia’s Lupkynis (voclosporin) have been important advances in the treatment arsenal for lupus nephritis (LN), a serious complication of systemic lupus ...

Belimumab added to standard of care (SoC) induction therapy controls disease activity and reduces steroid use in patients with proliferative lupus nephritis (LN), a real-world study shows.

“We are thrilled to achieve this milestone that will provide access to LUPKYNIS in Japan, where there is a high rate of lupus nephritis among Japanese lupus patients. Our successful strategic ...

The study population was representative of the real-world population of people with lupus nephritis. The primary endpoint was the proportion of people who achieved complete renal response (CRR) at 76 ...